Abstract:The natural history of COPD is complex, and the disease is best understood as a syndrome resulting from numerous interacting factors throughout the life cycle with smoking being the strongest inciting feature. Unfortunately, diagnosis is often delayed with several longitudinal cohort studies shedding light on the long 'preclinical' period of COPD. It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease. This includes its inception, early stages and progression to established disease. Several scenarios regarding lung function course are possible, but it may conceptually be helpful to distinguish between individuals with normal maximally attained lung function in their early adulthood who thereafter experience faster than normal FEV1 decline, and those who may achieve a lower than normal maximally attained lung function. This may be the main mechanism behind COPD in the latter group, as the decline in FEV1 during their adult life may be normal or only slightly faster than normal. Regardless of the FEV1 trajectory, continuous smoking is strongly associated with disease progression, development of structural lung disease and poor prognosis. In developing countries, factors such as exposure to biomass and sequelae after tuberculosis may lead to a more airway‐centred COPD phenotype than seen in smokers. Mechanistically, COPD is characterized by a combination of structural and inflammatory changes. It is unlikely that all patients share the same individual or combined mechanisms given the heterogeneity of resultant phenotypes. Lung explants, bronchial biopsies and other tissue studies have revealed important features. At the small airway level, progression of COPD is clinically imperceptible, and the pathological course of the disease is poorly described. Asthmatic features can further add confusion. However, the small airway epithelium is likely to represent a key focus of the disease, combining impaired subepithelial crosstalk and structural/inflammatory changes. Insufficient resolution of inflammatory processes may facilitate these changes. Pathologically, epithelial metaplasia, inversion of the goblet to ciliated cell ratio, enlargement of the submucosal glands and neutrophil and CD8‐T‐cell infiltration can be detected. Evidence of type 2 inflammation is gaining interest in the light of new therapeutic agents. Alarmin biology is a promising area that may permit control of inflammation and partial reversal of structural changes in COPD. Here, we review the latest work describing the development and progression of COPD with a focus on lung function trajectories, exacerbations and survival. We also review mechanisms focusing on epithelial changes associated with COPD and lack of resolution characterizing the underlying inflammatory processes.

Risk factors associated with irreversible airflow limitation in asthma

Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process

Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course

Asthma remission: does it exist?

The role of atopy in asthma development and persistence

Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions

Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study

Asthma transition from childhood into adulthood

Clinical assessment of asthma progression in children and adults

Airway remodelling in asthma and the epithelium: on the edge of a new era

Prevalence and etiotypes of persistent airflow obstruction in the general population ACROSS THE LIFETIME

Identifying risk factors for COPD and adult-onset asthma: an umbrella review

Clinical implications of airway obstruction with normal or low FEV 1 in childhood and adolescence

Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives

Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing

Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction

Biologics and Airway Remodeling in Severe Asthma

Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study

Natural history and mechanisms of COPD

The natural history of severe asthma and influences of early risk factors: a population-based cohort study